Correlation Between YS Biopharma and Addex Therapeutics

Can any of the company-specific risk be diversified away by investing in both YS Biopharma and Addex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining YS Biopharma and Addex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between YS Biopharma Co and Addex Therapeutics, you can compare the effects of market volatilities on YS Biopharma and Addex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in YS Biopharma with a short position of Addex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of YS Biopharma and Addex Therapeutics.

Diversification Opportunities for YS Biopharma and Addex Therapeutics

Very poor diversification

The 3 months correlation between YS Biopharma and Addex is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding YS Biopharma Co and Addex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Addex Therapeutics and YS Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on YS Biopharma Co are associated (or correlated) with Addex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Addex Therapeutics has no effect on the direction of YS Biopharma i.e., YS Biopharma and Addex Therapeutics go up and down completely randomly.

Pair Corralation between YS Biopharma and Addex Therapeutics

Allowing for the 90-day total investment horizon YS Biopharma Co is expected to under-perform the Addex Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, YS Biopharma Co is 2.14 times less risky than Addex Therapeutics. The stock trades about -0.55 of its potential returns per unit of risk. The Addex Therapeutics is currently generating about -0.12 of returns per unit of risk over similar time horizon. If you would invest  48.00  in Addex Therapeutics on July 1, 2023 and sell it today you would lose (11.00) from holding Addex Therapeutics or give up 22.92% of portfolio value over 90 days.

YS Biopharma Co  vs.  Addex Therapeutics

YS Biopharma

YS Biopharma Performance

0 of 100

Over the last 90 days YS Biopharma Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in October 2023. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Addex Therapeutics

Addex Performance

0 of 100

Over the last 90 days Addex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in October 2023. The recent disarray may also be a sign of long period up-swing for the firm insiders.

Pair Trading with YS Biopharma and Addex Therapeutics

The main advantage of trading using opposite YS Biopharma and Addex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if YS Biopharma position performs unexpectedly, Addex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will offset losses from the drop in Addex Therapeutics' long position.

The idea behind YS Biopharma Co and Addex Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.